239 Pan-HER trosine-kinase inhibitors (TKI) dacomitinib and afatinib in penile squamous cell carcinoma (PSCC): Results from an ongoing open-label, single-group, phase 2 trial of dacomitinib in chemonaive patients (pts)
Necchi, A., Raggi, D., Giannatempo, P., Nicolai, N., Colecchia, M., Calareso, G., Togliardi, E., Crippa, F., Mariani, L., Perrone, F., Pelosi, G., Salvioni, R., Sonpavde, G.Volume:
15
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(16)60241-5
Date:
March, 2016
File:
PDF, 201 KB
english, 2016
File converter
More search results
More benefits 
